Search

Your search for "inm" returned the following results.
Filter Results:
InvestorNewsBreaks

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Close on $6M Private Placement Funding

November 22, 2022

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, has closed on a private placement with two healthcare-focused institutional investors. The placement included the sale of 1,818,185 INM common shares, which were issued at a purchase price of $3.30 per share (or prefunded warrant in […]

InvestorNewsBreaks

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Anticipated $6M Private Placement Funding

November 18, 2022

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, has entered into a securities purchase agreement with two healthcare-focused institutional investors. The agreement outlines plans for the issuance and sale of 1,818,185 of INM common shares; the shares will be issued at a purchase price […]

InvestorNewsBreaks

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Accounting VP, Controller

November 17, 2022

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, has named Sarah Li as vice president of accounting and InMed controller; the change will be effective Nov. 20, 2022. Li is replacing Brenda Edwards, who has been serving as interim chief financial officer for the […]

InvestorNewsBreaks

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Gains Alliance Grant Funding, Launches New Program with UBC Professor

November 16, 2022

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, has unveiled a new neurodegenerative disease program (“INM-900 series”). The program will focus on studying the effects of cannabinoid analogs in neurodegenerative diseases such as Alzheimer’s, Huntington’s and Parkinson’s. Prior to this announcement, InMed had identified […]

InvestorNewsBreaks

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Q1 2023 Financial Report, Corporate Update

November 14, 2022

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing and clinical development of rare cannabinoids, has reported its financial results for the first quarter of fiscal year 2023, ended Sept. 30, 2022. Highlights of the report included updates on the company’s pharmaceutical development programs, including INM-755 for the treatment of epidermolysis bullosa (“EB”) and INM-088 for […]

InvestorNewsBreaks

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at ‘Exploring the Neuroprotective Qualities of Rare Cannabinoids’ Webinar Event

November 10, 2022

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, today announced that its CEO Eric A. Adams and SVP of Preclinical Research and Development Eric Hsu will present at Tribe Public’s upcoming webinar presentation and Q&A event. Titled “Exploring the Neuroprotective Qualities of Rare Cannabinoids,” […]

InvestorNewsBreaks

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Support of EB Awareness Week

October 26, 2022

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development and manufacturing of rare cannabinoids, today announced that it is supporting initiatives to raise awareness of epidermolysis bullosa, a group of rare genetic connective tissue disorders. Epidermolysis Bullosa Global Awareness Week is Oct. 25-31, 2022. “In severe cases of epidermolysis bullosa, or EB, the very […]

News Articles

Crypto Fest 2022 Gears Up for Networking and Entertainment for the Crypto-Defi-NFT-Web3 Community

September 26, 2022

The 4th edition of the Crypto Fest 2022 is being held on September 30, 2022, as a hybrid event in Cape Town, South Africa, and via live stream. Enthusiasts, businesses, and traders all over the world looking forward to the event can participate virtually. The Crypto Fest, in collaboration with the SA Innovation Summit, the largest […]

InvestorNewsBreaks

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces 2022 Financial Results, Business Update

September 23, 2022

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, today reported financial results for the fiscal year ended June 30, 2022. “In the final quarter of our fiscal 2022, as well as throughout the previous fiscal year, we have made important advancements in our pharmaceutical […]

InvestorNewsBreaks

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Plans to Release FY 2022 Financial Report, Corporate Update

September 20, 2022

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development and manufacturing of rare cannabinoids, will be releasing its financial report for fiscal year 2022, the period ended June 30, 2022, later this month. The company has announced that it will release the financial report, along with business highlights, on Sept. 23, 2022. In addition, […]

InvestorNewsBreaks

InvestorNewsBreaks – PIXELYNX Announces Key Partnership with Entertainment Executive, Visual Effects Pioneer

September 16, 2022

PIXELYNX, the music metaverse gaming platform founded by groundbreaking electronic musicians and technology visionaries Joel Zimmerman, aka deadmau5, and Richie Hawtin, aka Plastikman, has partnered with producer Ed Ulbrich, a pioneer in the visual effects space. Named by “Fast Company” magazine as one of the 100 most creative people in the business, Ulbrich will serve as […]

Press Releases

PIXELYNX Names Entertainment Executive and Visual Effects Pioneer Ed Ulbrich as Strategic Partner

September 15, 2022

LONDON and LOS ANGELES, Sept. 15, 2022 (GLOBE NEWSWIRE) — via InvestorWire – PIXELYNX, the music metaverse™ gaming platform founded by groundbreaking electronic musicians and technology visionaries Joel Zimmerman aka deadmau5 and Richie Hawtin aka Plastikman, announced today that producer and visual effects pioneer Ed Ulbrich has signed on as a strategic partner and advisor to the company. Ulbrich produced the epic sci-fi […]

InvestorNewsBreaks

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Closes $6M Private Placement Agreement

September 14, 2022

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development and manufacturing of rare cannabinoids, has closed on a private placement agreement with two healthcare-focused institutional investors. The agreement consisted of the issue and sale of 691,245 of INM common shares prices at $8.68 per share (or prefunded warrant in lieu thereof), totaling approximately $6 […]

InvestorNewsBreaks

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Enters into $6M Securities Purchase Agreement

September 12, 2022

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development and manufacturing of rare cannabinoids, has announced a private placement agreement with two healthcare-focused institutional investors. The agreement calls for the issuance and sale of 691,245 of INM common shares; the shares will be sold at a purchase price of $8.68 per share in a […]

InvestorNewsBreaks

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Update on Company Objectives and Programs

September 9, 2022

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development and manufacturing of rare cannabinoids and cannabinoid analogs, is reporting an update on the company’s research/development and commercial activities. According to the update, the company is working to complete enrollment in a phase 2 clinical program in epidermolysis bullosa (‘EB’) by the end of 2023, […]

InvestorNewsBreaks

InvestorNewsBreaks – Coinbase Global Inc. (NASDAQ: COIN) Collaborates with Integrated Gaming Entertainment Company

September 8, 2022

Coinbase (NASDAQ: COIN), one of the world’s largest cryptocurrency platforms and a trusted leader in the Web3 space, has entered a strategic collaboration with Enthusiast Gaming Holdings Inc. (NASDAQ: EGLX) (TSX: EGLX), an integrated gaming entertainment company. Under the partnership, Coinbase will provide developer tools, educational content and community-building support to power Enthusiast Gaming’s portfolio […]

InvestorNewsBreaks

InvestorNewsBreaks – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Announces Joint Agreement, Expanded Opportunity in Overseas Gaming Market

September 6, 2022

Blue Hat (NASDAQ: BHAT) today announced its entry into an agreement with a leading game distributor, Xiamen Traveler Network Technology Co. Ltd. (“TravelerNetwork”). Under the joint operating agreement, TravelerNetwork will distribute Blue Hat’s proprietary games “cute monopoly” and “cute game box” worldwide. According to management commentary provided in the news release, “TravelerNetwork has excellent global […]

InvestorNewsBreaks

InvestorNewsBreaks – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Enters MOU to Acquire 100% Equity of Shengruihao

August 26, 2022

Blue Hat (NASDAQ: BHAT) today announced that its wholly owned subsidiary, Xiamen Duwei Consulting Management Co. Ltd, entered into a memorandum of understanding (“MOU”) with its shareholder of Xiamen Shengruihao Technology Co. Ltd. (“Shengruihao”) to acquire 100% of the equity interests of Shengruihao, a company specialized in product supply chain and integrated enterprise services. “I […]

InvestorNewsBreaks

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Board Appointment, Changes

August 9, 2022

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today announced the appointment of Nicole Lemerond to its board of directors, effective immediately. Lemerond is a financial executive with over 25 years of experience in investment management, private equity, investment banking and leveraged finance. Throughout her career, she […]

InvestorNewsBreaks

InvestorNewsBreaks – Veritone Inc. (NASDAQ: VERI) Announces Continued Support for AWS Media & Entertainment Initiative

August 8, 2022

Veritone (NASDAQ: VERI), creator of aiWARE(TM), a hyper-expansive enterprise artificial intelligence (“AI”) platform, has announced an extension of its work with Amazon (NASDAQ: AMZN) and Amazon Web Services (“AWS”) to support its Media & Entertainment (“M&E”) customers. According to the update, Veritone last year joined the AWS for M&E initiative that helped content creators, rights […]

InvestorNewsBreaks

InvestorNewsBreaks – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) New Business Strategy Game Enables Players to Become Millionaires

August 5, 2022

Blue Hat Interactive (NASDAQ: BHAT), a leading communication services and internet data center (“IDC”) business provider, producer and developer, and an operator of mobile games and augmented reality (“AR”) education curricula and products in China, is planning the release of a new game. The company has created a simulated business strategy game, called Cute Monopoly; […]

InvestorNewsBreaks

InvestorNewsBreaks – Sanwire Corporation (SNWR) Subsidiary Inks Agreement with Litco Entertainment to Create Urban Music Label

July 26, 2022

Sanwire (OTC: SNWR), a diversified company with a focus on technologies for the entertainment space, through its wholly owned subsidiary, Intercept Music, has entered into a multiyear marketing and distribution partnership deal with Litco Entertainment. With offices in the United States, Mexico and Brazil, Litco is a global leader in urban marketing. The company has […]

InvestorNewsBreaks

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Issues Update on Phase 2 EB Trial

July 25, 2022

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today provided an update on its phase 2 clinical trial using investigational drug INM-755 cannabinol (“CBN”) cream for the treatment of patients with epidermolysis bullosa (“EB”). Based on safety data of the first five adult patients who completed the […]

InvestorNewsBreaks

InvestorNewsBreaks – Sycamore Entertainment Group Inc. (SEGI) Featured in Bell2Bell Podcast

July 21, 2022

Sycamore Entertainment Group (OTC: SEGI), a diversified entertainment company, was featured in the Bell2Bell Podcast, a part of IBN’s (InvestorBrandNetwork) sustained effort to provide specialized content distribution via widespread syndication channels. Edward Sylvan, co-founder and CEO of Sycamore Entertainment Group, joined the latest episode to provide an introduction to the company and discuss its business […]

Press Releases

IBN (InvestorBrandNetwork) Announces Latest Episode of The Bell2Bell Podcast featuring Edward Sylvan, CEO of Sycamore Entertainment Group Inc.

LOS ANGELES, July 21, 2022 (GLOBE NEWSWIRE) — via InvestorWire – IBN (InvestorBrandNetwork), a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The Bell2Bell Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. The Bell2Bell Podcast delivers informative updates […]

InvestorNewsBreaks

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Appoints Michael Woudenberg as Chief Operating Officer

July 18, 2022

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today announced its appointment of Michael Woudenberg as chief operating officer of the company, overseeing all day-to-day operations. Woudenberg previously served as senior vice president of chemistry, manufacturing and controls. For the past several years, he has been an […]

InvestorNewsBreaks

InvestorNewsBreaks – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Announces US$3.6M Registered Direct Offering

July 12, 2022

Blue Hat (NASDAQ: BHAT) is a producer, developer and operator of augmented reality interactive entertainment games, toys and educational materials in China. The company today announced its entry into two securities purchase agreements with two accredited investors for the total sale of 1,000,000 ordinary shares, par value $0.01 per share, of the company (“ordinary shares”) […]

InvestorNewsBreaks

InvestorNewsBreaks – Why Sycamore Entertainment Group Inc. (SEGI) Is ‘One to Watch’

July 8, 2022

Sycamore Entertainment Group (OTC: SEGI), a diversified entertainment company, through its wholly owned subsidiary, SEGI.TV, offers a streaming experience built on the pillars of equality, sustainability and community. SEGI.TV launched in late 2020 and is set to reach 100 million U.S. household televisions and 200 million mobile devices through Roku, Amazon Fire TV, Apple TV, […]

InvestorNewsBreaks

InvestorNewsBreaks – Sycamore Entertainment Group Inc. (SEGI) Engages IBN for Corporate Communications Expertise

June 30, 2022

Sycamore Entertainment Group (OTC: SEGI), a diversified entertainment company, today announced that it has selected the corporate communications expertise of IBN, a multifaceted financial news and publishing company for private and public entities. Through its wholly owned subsidiary SEGI.TV, Sycamore’s streaming experience is built on the pillars of equality, sustainability and community, offering movies and […]

Press Releases

IBN (InvestorBrandNetwork) Coverage Initiated for Sycamore Entertainment Group Inc.

LOS ANGELES, June 30, 2022 (GLOBE NEWSWIRE) — via InvestorWire – Sycamore Entertainment Group Inc. (OTC: SEGI), a diversified entertainment company, today announces it has selected the corporate communications expertise of IBN, a multifaceted financial news and publishing company for private and public entities. Through wholly owned subsidiary SEGI.TV, Sycamore offers a streaming experience built on the pillars of […]

News Articles

Sycamore Entertainment Group Inc. (SEGI) Is ‘One to Watch’

June 29, 2022

Sycamore Entertainment Group Inc., through subsidiary SEGI.TV, offers a streaming experience built on the pillars of equality, sustainability and community SEGI.TV is scheduled to reach 100 million U.S. household televisions and 200 million mobile devices through Roku, Amazon Fire TV, Apple TV, Samsung Smart TV and others Sycamore has entered sponsorship agreements for multiple motorsports […]

InvestorNewsBreaks

InvestorNewsBreaks – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Announces Proposed Underwritten Public Offering

June 21, 2022

Blue Hat (NASDAQ: BHAT), a producer, developer and operator of augmented reality interactive entertainment games, toys and educational materials in China, has announced its intention to offer, in an underwritten public offering, its ordinary shares and pre-funded warrants to purchase ordinary shares. The pre-funded warrants shall be offered at the same price per share as […]

InvestorNewsBreaks

InvestorNewsBreaks – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Notified by NASDAQ, Regains Compliance

June 15, 2022

Blue Hat Interactive (NASDAQ: BHAT), a leading communication services and internet data center (“IDC”) business provider, producer and developer, and an operator of mobile games and augmented reality (“AR”) education curricula and products in China, has regained compliance with NASDAQ minimum bid price requirement. The company was notified by the Listing Qualifications Department of Nasdaq […]

InvestorNewsBreaks

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Results of Peer-Reviewed Study Published in International Journal

June 14, 2022

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, has had its peer-reviewed scientific study published in the “International Journal of Molecular Sciences.” Titled “Effects of Rare Phytocannabinoids on the Endocannabinoid System of Human Keratinocytes,” the article reports on the study’s efforts to examine the biological activity of […]

InvestorNewsBreaks

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expands Portfolio of Rare Cannabinoids with Launch of d9-THCV

June 9, 2022

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today announced its launch of B2B sales of the rare cannabinoid delta 9-dominant tetrahydrocannabivarin (“d9-THCV”) into the health and wellness sector via its wholly owned subsidiary, BayMedica LLC. “We are very excited to launch our highly anticipated d9-THCV and […]

InvestorNewsBreaks

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Closes $5M Direct, Private Placement Offerings

June 7, 2022

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, has closed on its registered direct offering and concurrent private placement with a single healthcare-focused institutional investor; the offerings were priced at-the-market under Nasdaq rules. According to the announcement, for the registered direct offering, INM issued 4,079,256 common shares […]

InvestorNewsBreaks

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces $5M Registered Direct and Private Placement Offerings

June 2, 2022

InMed Pharmaceuticals (NASDAQ: INM) is a leader in the research, development, manufacturing and commercialization of rare cannabinoids. The company today announced its entry into securities purchase agreements with a single health care-focused institutional investor for the issuance and sale of 4,079,256 of its common shares, each at a purchase price of $0.858 (or pre-funded warrant […]

InvestorNewsBreaks

InvestorNewsBreaks – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Announces 1-for-10 Reverse Stock Split

May 26, 2022

Blue Hat (NASDAQ: BHAT), a Cayman Islands company, today announced that it expects to implement a 1-for-10 reverse stock split on its ordinary shares effective Friday, May 27, 2022, with trading to begin on a split-adjusted basis at the market open on that day. Ordinary shares will continue trading on the Nasdaq Capital Market under […]

InvestorNewsBreaks

InvestorNewsBreaks – Ryoshis Vision (‘$RYOSHI’) Aims to Disrupt Entertainment and Technology Sectors

May 24, 2022

As the rise of a new crypto era begins, with mass adoption on the horizon from institutions and individuals, Ryoshis Vision (“$RYOSHI”) takes a revolutionary approach to create a burning protocol solution for the Shiba Inu ecosystem. With plans of turning into a decentralized autonomous organization (“DAO”), Ryoshis Vision is focused on disrupting the entertainment […]

InvestorNewsBreaks

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Q3 Fiscal 2022 Financial Results, Provides Business Update

May 13, 2022

InMed Pharmaceuticals (NASDAQ: INM) is a leader in the research, development, manufacturing and commercialization of rare cannabinoids. The company today announced financial results for the third quarter ended March 31, 2022. “The third quarter of fiscal 2022 saw noticeable advancements across all of our programs, including commencing sales of the rare cannabinoids CBDV and CBT […]

No ResultsNo content matches your search/filter.

 

 

 

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(310) 299-1717

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).